Skip to main content

Table 2 Type-specific HPV detection in β-globin- and HPV-positive cervical cancers

From: Invasive cervical cancers from women living in the United States or Botswana: differences in human papillomavirus type distribution

HPV Type

U.S., N = 46

Botswana, N = 136

p-value

  

High-risk type distribution

 

HR-HPV

46 (100%)

130 (95.6%)

p = 0.3401

HPV 16

40 (87.0%)

58 (42.7%)

p < 0.0012

HPV 18

4 (8.7%)

32 (23.5%)

p = 0.0292

HPV26

0

5 (3.7%)

p = 0.3321

HPV31

1 (2.2%)

5 (3.7%)

p = 1.0001

HPV33

1 (2.2%)

7 (5.2%)

p = 0.6821

HPV35

0

8 (5.9%)

p = 0.2051

HPV39

0

6 (4.4%)

p = 0.3401

HPV45

3 (6.5%)

12 (8.8%)

p = 0.7641

HPV51

0

3 (2.2%)

p = 0.5731

HPV52

0

4 (2.9%)

p = 0.5741

HPV53

0

1 (0.7%)

p = 1.0001

HPV56

0

0

 

HPV58

0

2 (1.5%)

p = 1.0001

HPV59

0

2 (1.5%)

p = 1.0001

HPV66

0

4 (2.9%)

p = 0.5741

HPV67

0

1 (0.7%)

p = 1.0001

HPV68

0

2 (1.5%)

p = 1.0001

HPV69

0

1 (0.7%)

p = 1.0001

HPV70

0

0

 

HPV73

0

0

 

HPV82

0

2 (1.5%)

p = 1.0001

HPVIS39

0

0

 
  

Low-risk type distribution

 

LR-HPV

0

12 (8.8%)

p = 0.0391

HPV6

0

1 (0.7%)

p = 1.0001

HPV11

0

1 (0.7%)

p = 1.0001

HPV40

0

1 (0.7%)

p = 1.0001

HPV42

0

0

 

HPV54

0

0

 

HPV55

0

1 (0.7%)

p = 1.0001

HPV61

0

0

 

HPV62

0

0

 

HPV71

0

0

 

HPV72

0

0

 

HPV81

0

1 (0.7%)

p = 1.0001

HPV83

0

2 (1.5%)

p = 1.0001

HPV84

0

6 (4.4%)

p = 0.3401

  1. 1Fisher’s exact test, 2Chi-square test.